Objective: To design and validate a disease-specific health status instrume
nt-the Tonsil and Adenoid Health Status Instrument-for use in children with
tonsil and adenoid disease.
Design: Prospective psychometric and clinimetric instrument validation in 3
stages.
Settings: A tertiary academic pediatric specialty hospital and a tertiary a
cademic hospital, in 2 different cities.
Patients/Other Participants: Children with tonsil and adenoid disease prese
nting for evaluation and treatment(n=224).
Intervention/Method: Prospective instrument validation. Stage 1 consisted o
f initial item testing, reduction, and subscale construction; stage 2, reli
ability and validity testing, factor analysis, and final item reduction; an
d stage 3, responsiveness analysis.
Main Outcome Measures: Test-retest and internal consistency reliability; co
ntent, construct, and criterion validity; orthogonal principal components f
actor analysis; and response sensitivity analysis.
Results: Factor analysis and item analysis confirmed 6 distinct subscales m
easuring different constructs (aspects) of disease-specific health status t
hat are affected by tonsil and adenoid disease: eating and swallowing, airw
ay and breathing, infections, health care utilization, cost of care, and be
havior. For each subscale, the Tonsil and Adenoid Health Status Instrument
demonstrated excellent test-retest reliability (r=0.72-0.88) and internal c
onsistency reliability (Cronbach alpha=.73-.87). Content validity was ensur
ed during the design process. Construct validity was demonstrated by means
of convergent and divergent validity with a global quality-of-life instrume
nt (the Child Health Questionnaire, version PF28). Criterion validity was a
lso satisfactory. Finally, the instrument was appropriately sensitive, with
high standardized response means and effect sizes.
Conclusions: The Tonsil and Adenoid Health Status Instrument is a valid, re
liable, and sensitive instrument with 6 distinct subscales. This instrument
has significant utility for outcomes research in children with tonsil and
adenoid disease.